SFINX—a drug-drug interaction database designed for clinical decision support systems
about
Adherence to drug label recommendations for avoiding drug interactions causing statin-induced myopathy--a nationwide register studyAdherence to guidelines for avoiding drug interactions associated with warfarin--a Nationwide Swedish Register StudyNational Rules for Drug-Drug Interactions: Are They Appropriate for Tertiary Hospitals?DRUG-DRUG INTERACTION PROFILES OF MEDICATION REGIMENS EXTRACTED FROM A DE-IDENTIFIED ELECTRONIC MEDICAL RECORDS SYSTEMPotentially severe drug-drug interactions among older people and associations in assisted living facilities in Finland: a cross-sectional studyInformation needs for making clinical recommendations about potential drug-drug interactions: a synthesis of literature review and interviews.A conceptual model for translating omic data into clinical actionNationwide drug-dispensing data reveal important differences in adherence to drug label recommendations on CYP2D6-dependent drug interactions.Prevalence, nature and potential preventability of adverse drug events - a population-based medical record study of 4970 adults.Differences of Reasons for Alert Overrides on Contraindicated Co-prescriptions by Admitting DepartmentPolypharmacy in chronic diseases-Reduction of Inappropriate Medication and Adverse drug events in older populations by electronic Decision Support (PRIMA-eDS): study protocol for a randomized controlled trialThe continuing challenge of providing drug information services to diminish the knowledge--practice gap in medical practice.On the alert: future priorities for alerts in clinical decision support for computerized physician order entry identified from a European workshopNational indicators for quality of drug therapy in older persons: the Swedish experience from the first 10 years.Physicians' reported needs of drug information at point of care in Sweden.Development of a computerised decisions support system for renal risk drugs targeting primary healthcareConsensus recommendations for systematic evaluation of drug-drug interaction evidence for clinical decision support.Potentially inappropriate prescribing and adverse drug reactions in the elderly: a population-based study.Natural history of bleeding and characteristics of early bleeders among warfarin initiators - a cohort study in Finland.Implementing an evidence-based computerized decision support system to improve patient care in a general hospital: the CODES study protocol for a randomized controlled trialInformatics confronts drug-drug interactionsImplementing an evidence-based computerized decision support system linked to electronic health records to improve care for cancer patients: the ONCO-CODES study protocol for a randomized controlled trial.A critical evaluation of clinical decision support for the detection of drug-drug interactions.Cytochrome P450-mediated changes in oxycodone pharmacokinetics/pharmacodynamics and their clinical implications.Drug-drug interaction software in clinical practice: a systematic review.Co-Prescribing of Potentially Interacting Drugs during Warfarin Therapy - A Population-Based Register Study.Potential drug-drug interactions in paediatric outpatient prescriptions in Nigeria and implications for the future.The effect of amiodarone on warfarin anticoagulation: a register-based nationwide cohort study involving the Swedish population.The effect of carbamazepine on warfarin anticoagulation: a register-based nationwide cohort study involving the Swedish population.Analysis and prediction of drug-drug interaction by minimum redundancy maximum relevance and incremental feature selection.Prevalence of Drug Combinations Increasing Bleeding Risk Among Warfarin Users With and Without Alzheimer's Disease.Drug-drug Interaction Extraction via Hierarchical RNNs on Sequence and Shortest Dependency Paths.Post-mortem ABCB1 genotyping reveals an elevated toxicity for female digoxin users.Drugs and Birth Defects: a knowledge database providing risk assessments based on national health registers.Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care.Use of an on-demand drug-drug interaction checker by prescribers and consultants: a retrospective analysis in a Swiss teaching hospital.CYP2D6-inhibiting drugs and the increased risk of fall-related injuries due to newly initiated opioid treatment--a Swedish, register-based case-crossover study.A limited number of prescribed drugs account for the great majority of drug-drug interactions.Clinical pharmacology in everyday clinical care.Development and pilot testing of PHARAO-a decision support system for pharmacological risk assessment in the elderly.
P2860
Q28535157-FE87ACA2-69D3-4881-9A44-4264F27AD9F4Q28538870-58949945-66DE-4E67-8F4F-851C7117B325Q28596025-A56E1FDC-5DE9-400E-B20B-4A8E248E38B9Q28828695-D922C85F-F3E0-4338-BB2E-484B37A787DDQ28829102-3AE2AE21-81A2-4385-8763-AE10DFC57FD9Q30839776-89DB5EA2-DF7D-4293-BB1A-81F3CBBF06DEQ31000681-64739126-F030-43D6-8AFB-852D405109E7Q33560299-FC17E8AE-4A0F-45B8-98BA-6FBBE01EAAE7Q34209590-7CE33A34-8B29-45EB-844F-C66401CFAB03Q34506982-82EE28E2-DF10-4C68-8FC6-ABFF55005F0CQ34511248-356E3E60-36A2-4817-80B7-B2D3BA60A5C6Q34703735-B4AFB6EA-FB00-4B84-8D68-80FE2DE56D3BQ35003609-608C364F-D5CC-4B4C-B001-C8BDB262CC34Q35197166-36234272-7A82-4B8D-B88C-AD6CBFC466AFQ35640474-4BD52985-0F02-4B47-938E-0CB3EDB74F93Q35844071-3AC8EBF0-7494-4A2E-B61B-EE2A628C4760Q36219247-B2DBC920-3836-42AC-A1AF-377D0152CFB8Q36275087-7B049EE8-9B84-43E5-BF18-A5119CDCC064Q36575256-416369D3-4A84-4ED5-ABAF-9BE6FF98E92FQ37073780-4351518A-DA13-40B5-A67E-640471C7BC04Q37257012-8F477328-51F1-4626-BF03-998CA9CA14B6Q37440138-63DC7B1F-0EFF-41C7-9E02-90B7A7E9970AQ37871982-9EE37790-4EC1-4739-93E6-A88569937673Q38100710-07682EE9-833D-41A2-BB51-004DB3A4DB5EQ38295919-B3969E3F-E620-4864-8A1D-FA96F47D34A4Q38417110-1D060C09-2A97-4CE7-AB08-398B0FB5CABCQ38824529-BC8A93E5-A430-4DF7-9134-3328C572AF92Q39036774-C83B74FD-70D4-41CE-B8AD-8E5848B8DD2DQ40081501-D15A9E9A-7FE2-418A-ACB8-3F498780AAD9Q40124339-9DC2C8C0-D550-42C0-93CA-67DF313A0ECCQ40420203-5C3012CF-51BB-4F7A-ADE7-79525FF3D09DQ42695427-AF1D94A8-8EC7-4BDC-AA6D-566F58D6A59FQ42751321-9640521E-8512-42B8-8B72-BB61563ADCA0Q43675521-3358974B-0C58-4EAD-A207-A89AF7D0AABDQ43797117-D23C32CA-6985-4F2C-832E-B4EE07C549A4Q43898021-9C8F9133-C868-4997-8D65-944692582BD0Q44345641-8298C680-AB0C-4119-B6ED-B43FF3858EA0Q44904056-8BB78888-142D-4D6D-B0B1-7001B45E0044Q45142665-EF5706F0-705D-4AB0-A2D1-8502431CACC6Q47379300-44AA71F5-F08E-405D-9E9C-D625E913B505
P2860
SFINX—a drug-drug interaction database designed for clinical decision support systems
description
im Februar 2009 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в лютому 2009
@uk
name
SFINX—a drug-drug interaction database designed for clinical decision support systems
@en
SFINX—a drug-drug interaction database designed for clinical decision support systems
@nl
type
label
SFINX—a drug-drug interaction database designed for clinical decision support systems
@en
SFINX—a drug-drug interaction database designed for clinical decision support systems
@nl
prefLabel
SFINX—a drug-drug interaction database designed for clinical decision support systems
@en
SFINX—a drug-drug interaction database designed for clinical decision support systems
@nl
P2093
P50
P1476
SFINX—a drug-drug interaction database designed for clinical decision support systems
@en
P2093
Anders Rane
Birgit Eiermann
Björn Molin
Kari Laine
Marine L. Andersson
Tuomas Korhonen
Ylva Böttiger
P2860
P2888
P304
P356
10.1007/S00228-008-0612-5
P577
2009-02-11T00:00:00Z